The United Nations has allocated more than $2 million — yaani about 20 lakh US dollars, roughly KSh260 million (26 crore Kenyan shillings) — to strengthen Ebola preparedness and response in Kenya, the UN Office for the Coordination of Humanitarian Affairs (OCHA) said in a statement on Tuesday. The money comes through the Kenya Humanitarian Fund, which OCHA manages, and will support humanitarian partners working alongside the Kenyan government.

Source: People Daily (OCHA statement)

The funding will pay for enhanced surveillance at border crossing points, training for rapid response teams and front-line responders, emergency health and infection prevention kits, and public information campaigns on Ebola prevention and early detection. It will also support preparedness along high-risk refugee and travel routes linked to the Kakuma refugee complex in north-western Kenya, UN spokesperson Daniela De Almeida told journalists at UN headquarters in New York on Tuesday.

Source: News Agency of Nigeria via Uhuru Times

Kenya confirmed its first case of Bundibugyo virus disease — a form of Ebola — on October 6. As of October 20, nine confirmed cases, including two fatalities, had been reported, all linked to that first case, De Almeida said. There is no evidence of community transmission, but contact tracing has identified 134 additional people who may have been exposed, and they have been placed under quarantine. Kenyan reporting says the first case was a Kenyan citizen who had been living in the Democratic Republic of the Congo and travelled through Uganda before arriving in Nairobi on October 3.

Source: Radio Generation (OCHA)

9Confirmed Ebola cases in Kenya as of October 20
2Deaths among the confirmed cases
134Contacts identified and placed under quarantine
$2M+New UN allocation — about KSh260 million

Across the border, the World Health Organization has launched a clinical trial platform in the Democratic Republic of the Congo to evaluate vaccine candidates against Ebola. Dr Meg Doherty, director of the WHO's Department of Science for Health, announced the TUMAINI trial platform — 'tumaini' means 'hope' in Swahili — to journalists in Geneva, speaking from Bunia in eastern DRC. The platform will evaluate several vaccine candidates within one research framework using ring vaccination, the strategy of vaccinating contacts of confirmed cases. The first vaccine being evaluated is Ervebo, which is effective against the Zaire ebolavirus, but its efficacy against the Bundibugyo strain behind the current outbreak is unknown.

Source: News Agency of Nigeria via Realnews Magazine

Ebola transmission is continuing in the DRC itself, and the movement of people across the region's borders is the central risk officials are trying to contain — the reason preparedness money is flowing not only to Kenya but to exercises and screening in neighbouring countries such as South Sudan. For now, Kenyan authorities say the outbreak remains linked to a single imported case, and the test ahead is whether surveillance at borders and along travel routes catches any new importation before it spreads.